Furosemide

DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutica

Analyzing over US$ 90 billion of Medicare Prescription Drug (Part D) Spending in 2016

This week, PharmaCompass reviews the recently released data on prescription drugs paid for under th

Drug costs and prescription trends in the United States: Analyzing Medicare’s $121 billion spend

In less than three weeks, Donald Trump will assume office as the President of the United States. He

Ranbaxy’s path of deception revealed in Singapore court order; Chinese, Indian, American and Spanish firms in compliance troubles

This week, Phispers brings you the latest on the Ranbaxy-Daiichi and Merck-Gilead cases. There is al

The silver lining in Ipca’s Import Alert blues

Ipca Laboratories finished dosage facilities at Silvasa and Pithampur (India) were put on the FDA Im